VERMOX

Peak

mebendazole

NDAORALTABLET, CHEWABLEPriority Review
Approved
Oct 2016
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

Mebendazole, a benzimidazole, is an anthelmintic [see ] .

Pharmacologic Class:

Anthelmintic

Clinical Trials (5)

NCT02034162Phase 3Completed

A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants

Started Dec 2014
295 enrolled
Helminth Infections
NCT02051738Phase 1Completed

A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants

Started Feb 2014
1 enrolled
Healthy
NCT01837862Phase 1/2Completed

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Started Oct 2013
36 enrolled
Pilomyxoid AstrocytomaPilocytic AstrocytomaGlioma, Astrocytic+9 more
NCT01173562Phase 3Completed

A Safety Study of Mebendazole in Children 2 to 10 Years of Age

Started Feb 2010
397 enrolled
Healthy Volunteers
NCT02385058Phase 4Completed

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Started Oct 2005
100 enrolled
HelminthiasisAmoebiasis